Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Multi-Target Drugs Against Metabolic Disorders

Author(s): Luciana Scotti* and Marcus T. Scotti

Volume 19, Issue 4, 2019

Page: [389 - 390] Pages: 2

DOI: 10.2174/187153031904190506102405

Next »
[1]
Congenital anomalies fact sheet updated September 2016 http://www.who.int/mediacentre/factsheets/fs370/en/ (Accessed December 2017).
[2]
Metabolic disorders: MedlinePlus". www.nlm.nih.gov Retrieved 27 July 2015. https://medlineplus.gov/metabolicdisorders.html (Accessed December 2017).
[3]
Inherited Metabolic Disorders Overview: Overview, Clinical Features and Differential Diagnosis, Epidemiology and Statistics. (Accessed December 2017).
[4]
Scotti, L.; Monteiro, A.F.M.; Viana, J.O.; Mendonça Jr., F.J.B.; Ishiki, H.M.; Tchouboun, E.N.; Santos, R.; Scotti, M.T. Multi-target drugs against metabolic disorders. Endocr. Metab. Immune. Disord Drug Targets, 2019. 19(4), 402-418
[5]
Singla, R.K.; Dubey, A.K. Phytochemical profiling, gc-ms analysis and α-amylase inhibitory potential of ethanolic extract of Cocos nucifera Linn. Endocarp. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 419-442.
[6]
Khan, H.; Amin, D.; Tewari, D.; Nabavi, S.M.; Atanas, A.G. Plant derived glycosides with α-glucosidase inhibitory activity: Current standing and future prospects. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 391-401.
[7]
Hassan, F.; Qudus, M.S.; Sehgal, S.A.; Ahmed, J.; Khan, M. Haq, K ul; Mumtaz, S.; Arshad, M.; Siraj, S. Prevalence of extended spectrum β-lactamases in multi-drug resistant Pseudomonas aeruginosa from diabetic foot patients. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 443-448.
[8]
Panwar, U.; Singh, S.K. Identification of novel pancreatic lipase inhibitors using structure based virtual screening, docking and simulations studies. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 449-457.

Rights & Permissions Print Cite
Article Metrics
23
3
© 2024 Bentham Science Publishers | Privacy Policy